Davì G et al. |
In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. |
1999 |
Circulation |
pmid:9892587
|
McAdam BF et al. |
Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2. |
1999 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:9874808
|
Praticò D et al. |
Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2alpha-III, an index of oxidant stress. |
1998 |
Am. J. Respir. Crit. Care Med. |
pmid:9847257
|
Cullen L et al. |
Selective cyclooxygenase-2 inhibition by nimesulide in man. |
1998 |
J. Pharmacol. Exp. Ther. |
pmid:9808683
|
Obase Y et al. |
Effects of cysteinyl-leukotriene receptor antagonist, thromboxane A2 receptor antagonist, and thromboxane A2 synthetase inhibitor on antigen-induced bronchoconstriction in patients with asthma. |
1998 |
Chest |
pmid:9792572
|
Lindström T et al. |
The effect of unreamed and reamed intramedullary nailing on the urinary excretion of prostacyclin and thromboxane A2 metabolites in patients with tibial shaft fractures. |
1998 |
J Trauma |
pmid:9783614
|
Oosaki R et al. |
Correlation among urinary eosinophil protein X, leukotriene E4, and 11-dehydrothromboxane B2 in patients with spontaneous asthmatic attack. |
1998 |
Clin. Exp. Allergy |
pmid:9761018
|
Oosaki R et al. |
Urinary excretion of leukotriene E4 and 11-dehydrothromboxane B2 in patients with spontaneous asthma attacks. |
1997 |
Int. Arch. Allergy Immunol. |
pmid:9414142
|
Davì G et al. |
Enhanced thromboxane biosynthesis in patients with chronic obstructive pulmonary disease. The Chronic Obstructive Bronchitis and Haemostasis Study Group. |
1997 |
Am. J. Respir. Crit. Care Med. |
pmid:9412557
|
Davi G et al. |
In vivo formation of 8-Epi-prostaglandin F2 alpha is increased in hypercholesterolemia. |
1997 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:9409316
|
Farker K et al. |
Measurements of urinary prostaglandins in young ovulatory women during the menstrual cycle and in postmenopausal women. |
1997 |
Prostaglandins |
pmid:9373880
|
Lahoz C et al. |
Effects of dietary fat saturation on eicosanoid production, platelet aggregation and blood pressure. |
1997 |
Eur. J. Clin. Invest. |
pmid:9352251
|
van Kooten F et al. |
Platelet activation and lipid peroxidation in patients with acute ischemic stroke. |
1997 |
Stroke |
pmid:9259748
|
Rautanen M et al. |
Experimental fat embolism induces urine 2,3-dinor-6-ketoprostaglandin F1alpha and 11-dehydrothromboxane B2 excretion in pigs. |
1997 |
Crit. Care Med. |
pmid:9233750
|
Malini PL et al. |
Thromboxane antagonism and cough induced by angiotensin-converting-enzyme inhibitor. |
1997 |
Lancet |
pmid:9217714
|
Oosaki R et al. |
Urinary leukotriene E4 and 11-dehydrothromboxane B2 in patients with aspirin-sensitive asthma. |
1997 |
Allergy |
pmid:9188934
|
Bröijersén A et al. |
No influence of simvastatin treatment on platelet function in vivo in patients with hypercholesterolemia. |
1997 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:9081681
|
Reilly M et al. |
Modulation of oxidant stress in vivo in chronic cigarette smokers. |
1996 |
Circulation |
pmid:8964113
|
Milani M et al. |
Effects of two different HMG-CoA reductase inhibitors on thromboxane production in type IIA hypercholesterolemia. |
1996 |
Biomed. Pharmacother. |
pmid:8952866
|
Schaefer WR et al. |
Urinary excretion of 2,3-dinor-6-keto-PGF1 alpha and 11-dehydro-TXB2 by the gravid spontaneously hypertensive rat. |
1996 |
Prostaglandins |
pmid:8875634
|
Cuiper LL et al. |
Systemic and pulmonary hypertension after abrupt cessation of prostacyclin: role of thromboxane A2. |
1996 |
J. Appl. Physiol. |
pmid:8847301
|
Laffi G et al. |
Defective aggregation in cirrhosis is independent of in vivo platelet activation. |
1996 |
J. Hepatol. |
pmid:8738730
|
Stein CM et al. |
Evidence of free radical-mediated injury (isoprostane overproduction) in scleroderma. |
1996 |
Arthritis Rheum. |
pmid:8670323
|
Yamanaka S et al. |
11-Dehydro thromboxane B2: a reliable parameter of thromboxane A2 production in dogs. |
1993 |
Prostaglandins |
pmid:8484010
|
Yasu T et al. |
Effects of aspirin DL-lysine on thrombin generation in unstable angina pectoris. |
1993 |
Am. J. Cardiol. |
pmid:8480641
|
Ciabattoni G et al. |
Aspirin, but not heparin, suppresses the transient increase in thromboxane biosynthesis associated with cardiac catheterization or coronary angioplasty. |
1993 |
J. Am. Coll. Cardiol. |
pmid:8473644
|
Chen HI et al. |
Effects of exercise training on the biosynthesis of prostacyclin and thromboxane in rats. |
1993 |
Acta Physiol. Scand. |
pmid:8452036
|
Foulon I et al. |
Increased in vivo production of thromboxane in patients with sickle cell disease is accompanied by an impairment of platelet functions to the thromboxane A2 agonist U46619. |
1993 |
Arterioscler. Thromb. |
pmid:8443146
|
Koudstaal PJ et al. |
Increased thromboxane biosynthesis in patients with acute cerebral ischemia. |
1993 |
Stroke |
pmid:8421822
|
Van Assche FA et al. |
Increased thromboxane formation in diabetic pregnancy as a possible contributor to preeclampsia. |
1993 |
Am. J. Obstet. Gynecol. |
pmid:8420355
|
Schiff E et al. |
Reduction of thromboxane A2 synthesis in pregnancy by polyunsaturated fatty acid supplements. |
1993 |
Am. J. Obstet. Gynecol. |
pmid:8420313
|
Takasaki W et al. |
Superiority of plasma 11-dehydro-TXB2 to TXB2 as an index of in vivo TX formation in rabbits after dosing of CS-518, a TX synthase inhibitor. |
1993 |
Thromb. Res. |
pmid:8367836
|
Chiabrando C et al. |
Urinary excretion and origin of 11-dehydro-2,3-dinor-thromboxane B2 in man. |
1993 |
Prostaglandins |
pmid:8321910
|
Foegh ML et al. |
Urinary thromboxane A2 metabolites in patients presenting in the emergency room with acute chest pain. |
1994 |
J. Intern. Med. |
pmid:8308478
|
van Kooten F et al. |
Evidence for episodic platelet activation in acute ischemic stroke. |
1994 |
Stroke |
pmid:8303731
|
Smith SR et al. |
Chronic thromboxane synthase inhibition with CGS 12970 in human cyclosporine nephrotoxicity. |
1993 |
Transplantation |
pmid:8279014
|
Djurup R et al. |
Rapid, direct enzyme immunoassay of 11-keto-thromboxane B2 in urine, validated by immunoaffinity/gas chromatography-mass spectrometry. |
1993 |
Clin. Chem. |
pmid:8252718
|
Larsson PT et al. |
Norepinephrine-induced human platelet activation in vivo is only partly counteracted by aspirin. |
1994 |
Circulation |
pmid:8181117
|
Kitano A et al. |
Increased 11-dehydrothromboxane B2 in migraine: platelet hyperfunction in patients with migraine during headache-free period. |
1994 |
Headache |
pmid:8002323
|
Pape HC et al. |
Does the reamer type influence the degree of lung dysfunction after femoral nailing following severe trauma? An animal study. |
1994 |
J Orthop Trauma |
pmid:7965291
|
Wallén NH et al. |
Effects of treatment with oral isosorbide dinitrate on platelet function in vivo; a double-blind placebo-controlled study in patients with stable angina pectoris. |
1994 |
Br J Clin Pharmacol |
pmid:7946939
|
Chiabrando C et al. |
Urinary excretion of 2,3-dinor-thromboxane B1, a major metabolite of thromboxane B2 in the rat. |
1994 |
Prostaglandins |
pmid:7938613
|
Kawamura M et al. |
Evaluation of plasma 11-dehydro-thromboxane B2 as an indicator for thromboxane A2 synthesis in vivo in laboratory animals. |
1995 |
Thromb. Res. |
pmid:7778061
|
Schlit AF et al. |
Large increase in plasmatic 11-dehydro-TxB2 levels due to oral contraceptives. |
1995 |
Contraception |
pmid:7750285
|
Benowitz NL et al. |
Nicotine effects on eicosanoid formation and hemostatic function: comparison of transdermal nicotine and cigarette smoking. |
1993 |
J. Am. Coll. Cardiol. |
pmid:7691912
|
Milani M et al. |
Effects of fluvastatin and pravastatin on lipid profiles and thromboxane production in type IIa hypercholesterolemia. |
1995 |
Am. J. Cardiol. |
pmid:7604798
|
Ferretti A and Flanagan VP |
Mass spectrometric evidence for the anomalous chemical behavior of 11-dehydrothromboxane B2. |
1995 |
Chem. Phys. Lipids |
pmid:7586090
|
Cipollone F et al. |
Effects of nabumetone on prostanoid biosynthesis in humans. |
1995 |
Clin. Pharmacol. Ther. |
pmid:7554708
|
Jörres A et al. |
Urinary excretion of thromboxane and markers for renal injury in patients undergoing cardiopulmonary bypass. |
1994 |
Artif Organs |
pmid:7527629
|
Kumlin M and Granström E |
Radioimmunoassay for 11-dehydro-TXB2: a method for monitoring thromboxane production in vivo. |
1986 |
Prostaglandins |
pmid:3823488
|
Westlund P et al. |
Identification of 11-dehydro-TXB2 as a suitable parameter for monitoring thromboxane production in the human. |
1986 |
Prostaglandins |
pmid:3755250
|
Schweer H et al. |
Tandem mass spectrometric determination of 11-dehydrothromboxane B2, an index metabolite of thromboxane B2 in plasma and urine. |
1987 |
Anal. Biochem. |
pmid:3674365
|
Fitzgerald DJ et al. |
Increased thromboxane biosynthesis in normal pregnancy is mainly derived from platelets. |
1987 |
Am. J. Obstet. Gynecol. |
pmid:3618681
|
Ciabattoni G et al. |
Radioimmunoassay of 11-dehydrothromboxane B2 in human plasma and urine. |
1987 |
Biochim. Biophys. Acta |
pmid:3567215
|
Fitzgerald DJ et al. |
Platelet activation in unstable coronary disease. |
1986 |
N. Engl. J. Med. |
pmid:3531859
|
Westlund P et al. |
Circulating and urinary thromboxane B2 metabolites in the rabbit: 11-dehydro-thromboxane B2 as parameter of thromboxane production. |
1986 |
Prostaglandins |
pmid:3520685
|
Catella F et al. |
11-Dehydrothromboxane B2: a quantitative index of thromboxane A2 formation in the human circulation. |
1986 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:3461463
|
Alessandrini P et al. |
Thromboxane biosynthesis and platelet function in type I diabetes mellitus. |
1988 |
N. Engl. J. Med. |
pmid:3292913
|
Seyberth HW et al. |
Excretion of primary prostanoids and their metabolites during acute volume expansion. |
1988 |
Prostaglandins |
pmid:3163156
|
Lawson JA et al. |
Long-lived enzymatic metabolites of thromboxane B2 in the human circulation. |
1986 |
Anal. Biochem. |
pmid:3087234
|
|
|
|
|
pmid:28911508
|
|
|
|
|
pmid:28139223
|
|
|
|
|
pmid:28005558
|
|
|
|
|
pmid:27815971
|
|
|
|
|
pmid:27784132
|
|
|
|
|
pmid:27769511
|
Lorenz R et al. |
A new method using simple solid phase extraction for the rapid gas-chromatographic mass-spectrometric determination of 11-dehydro-thromboxane B2 in urine. |
1989 |
Prostaglandins |
pmid:2772221
|
|
|
|
|
pmid:27693274
|
|
|
|
|
pmid:27609361
|
Patrignani P et al. |
Fractional conversion of thromboxane A2 and B2 to urinary 2,3-dinor-thromboxane B2 and 11-dehydrothromboxane B2 in the cynomolgus monkey. |
1989 |
Biochim. Biophys. Acta |
pmid:2752041
|
Ciabattoni G et al. |
Fractional conversion of thromboxane B2 to urinary 11-dehydrothromboxane B2 in man. |
1989 |
Biochim. Biophys. Acta |
pmid:2752040
|
Maga P et al. |
11-dehydro thromboxane B2 levels after percutaneous transluminal angioplasty in patients with peripheral arterial occlusive disease during a one year follow-up period. |
2016 |
J. Physiol. Pharmacol. |
pmid:27511998
|
|
|
|
|
pmid:27481134
|
|
|
|
|
pmid:27389698
|
|
|
|
|
pmid:27237049
|
|
|
|
|
pmid:27137142
|
|
|
|
|
pmid:27098431
|
Kakouros N et al. |
Risk Factors for Nonplatelet Thromboxane Generation After Coronary Artery Bypass Graft Surgery. |
2016 |
J Am Heart Assoc |
pmid:27068626
|
Liu TF et al. |
[Correlation between the level of the urinary 11-dehydrothromboxane B2 and the clinical efficacy of aspirin in patients with type 2 diabetes and coronary artery disease]. |
2015 |
Beijing Da Xue Xue Bao |
pmid:26679651
|
Santilli F et al. |
Pentraxin 3 and Platelet Activation in Obese Patients After Gastric Banding. |
2016 |
Circ. J. |
pmid:26632534
|
Lüdicke F et al. |
A Japanese cross-sectional multicentre study of biomarkers associated with cardiovascular disease in smokers and non-smokers. |
2015 |
Biomarkers |
pmid:26616146
|
|
|
|
|
pmid:26385032
|
Di Minno MN et al. |
Increased platelet reactivity in Klinefelter men: something new to consider. |
2015 |
Andrology |
pmid:26216452
|
|
|
|
|
pmid:26095809
|
Lorenz RL et al. |
A critical evaluation of urinary immunoreactive thromboxane: feasibility of its determination as a potential vascular risk indicator. |
1989 |
Biochim. Biophys. Acta |
pmid:2597697
|
Véricel E et al. |
Moderate oral supplementation with docosahexaenoic acid improves platelet function and oxidative stress in type 2 diabetic patients. |
2015 |
Thromb. Haemost. |
pmid:25832443
|
|
|
|
|
pmid:25808116
|
|
|
|
|
pmid:25759102
|
|
|
|
|
pmid:25669623
|
|
|
|
|
pmid:25589198
|
|
|
|
|
pmid:25466142
|
|
|
|
|
pmid:25288566
|
Floyd CN et al. |
Increased platelet expression of glycoprotein IIIa following aspirin treatment in aspirin-resistant but not aspirin-sensitive subjects. |
2014 |
Br J Clin Pharmacol |
pmid:25099258
|
Lupinetti MD et al. |
Thromboxane biosynthesis in allergen-induced bronchospasm. Evidence for platelet activation. |
1989 |
Am. Rev. Respir. Dis. |
pmid:2508524
|
Lattanzio S et al. |
Circulating dickkopf-1 in diabetes mellitus: association with platelet activation and effects of improved metabolic control and low-dose aspirin. |
2014 |
J Am Heart Assoc |
pmid:25037197
|
Santilli F et al. |
Circulating myeloid-related protein-8/14 is related to thromboxane-dependent platelet activation in patients with acute coronary syndrome, with and without ongoing low-dose aspirin treatment. |
2014 |
J Am Heart Assoc |
pmid:25037196
|
|
|
|
|
pmid:24907931
|
|
|
|
|
pmid:24803308
|
Ross S et al. |
Association of cyclooxygenase-2 genetic variant with cardiovascular disease. |
2014 |
Eur. Heart J. |
pmid:24796340
|
|
|
|
|
pmid:24763965
|